Somite


Somite is building foundation models for human stem cells to transform the development of novel cell therapies. Their proprietary technology allows for unprecedented data generation, accelerating discovery and optimization of cell differentiation protocols. Backed by over $47 million in Series A funding led by Khosla Ventures, Somite aims to revolutionize regenerative medicine by enabling faster, cheaper, and more effective cell therapies, opening new therapeutic possibilities.

Industries

artificial-intelligence
biotechnology

Nr. of Employees

small (1-50)

Somite

Boston, Massachusetts, United States, North America


Products

Somite-derived Cell Therapy

A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.

Somite-derived Cell Therapy

A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.

Somite-derived Cell Therapy

A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.

Somite-derived Cell Therapy

A therapy that uses somite-derived cells to replace missing, damaged, or diseased cells for treating various medical conditions.

Digital Twin of the Embryo

A computational model simulating embryo development to guide decision-making in cell therapy protocols.

Digital Twin of the Embryo

A computational model simulating embryo development to guide decision-making in cell therapy and protocol optimization.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.